Kestra Medical Technologies, Ltd. officer Vaseem Mahboob filed a Form 144 notice of proposed sale on October 28, 2026, covering 39,903 shares of common stock to be sold through Merrill Lynch on NASDAQ.

Key Highlights

  • Proposed sale: Vaseem Mahboob, an officer of Kestra Medical Technologies, Ltd., filed notice to sell 39,903 shares of common stock with an aggregate market value of $1,216,393.08.
  • Acquisition method: The shares were acquired on October 28, 2026, through the exercise of employee stock options via a broker-assisted cashless exercise.
  • Shares outstanding: According to the filing, 59,561,795 shares of common stock were outstanding at the time of the notice.
  • Rule 10b5-1 plan: The filing indicates a trading plan adoption date of November 5, 2025.
  • Prior three-month sales: The filing discloses six prior sales by Mahboob between July 30, 2026, and October 27, 2026, totaling 86,279 shares and approximately $2,317,020.07 in gross proceeds across all transactions listed.
  • Broker: Merrill Lynch, 225 Liberty Street, Floor 37, New York, NY 10281, is named as the broker for the proposed sale.

Details of Mahboob's Proposed Sale and Recent Transaction History at Kestra Medical

According to the Form 144 filed with the U.S. Securities and Exchange Commission on October 28, 2026, Vaseem Mahboob, identified as an officer of Kestra Medical Technologies, Ltd. (NASDAQ:KMTS), proposed to sell 39,903 shares of the company's common stock. The filing lists an aggregate market value of $1,216,393.08 for these shares and names NASDAQ as the securities exchange on which the sale is to occur. The approximate date of sale is stated as October 28, 2026.

The filing discloses that the securities were acquired on October 28, 2026, through the exercise of employee stock options from Kestra Medical Technologies, Ltd., with the nature of payment described as a "broker assisted cashless exercise." The filing also notes that Mahboob adopted a written trading plan or gave trading instructions under Rule 10b5-1 on November 5, 2025.

The filing's required disclosure of securities sold in the past three months lists six transactions by Mahboob. These span from July 30, 2026, through October 27, 2026, and involve sales of 3,980 shares ($90,560.62), 8,817 shares ($199,344.62), 5,391 shares ($128,312.27), 6,995 shares ($172,634.70), 26,287 shares ($680,383.99), and 34,809 shares ($1,045,784.87), respectively, all in Kestra Medical common stock. The issuer's address is listed as 3933 Lake Washington Blvd NE, Suite 200, Kirkland, Washington 98033.

What Was Disclosed

Vaseem Mahboob, an officer of Kestra Medical Technologies, Ltd., filed a Form 144 on October 28, 2026, providing notice of a proposed sale of 39,903 common shares with an aggregate market value of $1,216,393.08, acquired through a cashless stock option exercise on the same date.